Search research articles
Contact Us
Filters
Showing results (41-50 of 91) with videos related to
Page
of 10
Sort By:
International Library of Diabetes & Metabolism
|
June 30, 2015
Protective Effect of Topiramate on Hyperglycemia-Induced Cerebral Oxidative Stress, Pericyte Loss and Learning Behavior in Diabetic Mice
Tulin O Price, Susan A Farr, Michael L Niehoff, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2010
Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor
William A Banks, Vijaya B Kumar, Susan A Farr, et al.
Journal of Neuroinflammation
|
November 13, 2020
Adenosine A<sub>3</sub> receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury
Susan A Farr, Salvatore Cuzzocrea, Emanuela Esposito, et al.
Frontiers in Neuroscience
|
April 1, 2017
A Life without Hunger: The Ups (and Downs) to Modulating Melanocortin-3 Receptor Signaling
Andrew A Butler, Clemence Girardet, Maria Mavrikaki, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 8, 2010
Transport across the blood-brain barrier of pluronic leptin
Tulin O Price, Susan A Farr, Xiang Yi, et al.
Journal of Alzheimer'S Disease : JAD
|
September 3, 2016
Peripheral Administration of GSK-3β Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease
Susan A Farr, Karin E Sandoval, Michael L Niehoff, et al.
European Journal of Pharmacology
|
March 28, 2012
Somatostatin receptor subtype-4 agonist NNC 26-9100 decreases extracellular and intracellular Aβ₁₋₄₂ trimers
Karin E Sandoval, Susan A Farr, William A Banks, et al.
Brain Research
|
May 15, 2013
Somatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ(42) oligomers via a metalloproteinase-dependent mechanism
Karin E Sandoval, Susan A Farr, William A Banks, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 8, 2010
Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice
William A Banks, John E Morley, Susan A Farr, et al.
Healthcare (Amsterdam, Netherlands)
|
June 20, 2020
Methods to identify dementia in the electronic health record: Comparing cognitive test scores with dementia algorithms
Barbara N Harding, James S Floyd, Jeffrey F Scherrer, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 91) with videos related to
Sort By:
Page
of 10
International Library of Diabetes & Metabolism
|
June 30, 2015
Protective Effect of Topiramate on Hyperglycemia-Induced Cerebral Oxidative Stress, Pericyte Loss and Learning Behavior in Diabetic Mice
Tulin O Price, Susan A Farr, Michael L Niehoff, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2010
Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor
William A Banks, Vijaya B Kumar, Susan A Farr, et al.
Journal of Neuroinflammation
|
November 13, 2020
Adenosine A<sub>3</sub> receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury
Susan A Farr, Salvatore Cuzzocrea, Emanuela Esposito, et al.
Frontiers in Neuroscience
|
April 1, 2017
A Life without Hunger: The Ups (and Downs) to Modulating Melanocortin-3 Receptor Signaling
Andrew A Butler, Clemence Girardet, Maria Mavrikaki, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 8, 2010
Transport across the blood-brain barrier of pluronic leptin
Tulin O Price, Susan A Farr, Xiang Yi, et al.
Journal of Alzheimer'S Disease : JAD
|
September 3, 2016
Peripheral Administration of GSK-3β Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease
Susan A Farr, Karin E Sandoval, Michael L Niehoff, et al.
European Journal of Pharmacology
|
March 28, 2012
Somatostatin receptor subtype-4 agonist NNC 26-9100 decreases extracellular and intracellular Aβ₁₋₄₂ trimers
Karin E Sandoval, Susan A Farr, William A Banks, et al.
Brain Research
|
May 15, 2013
Somatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ(42) oligomers via a metalloproteinase-dependent mechanism
Karin E Sandoval, Susan A Farr, William A Banks, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 8, 2010
Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice
William A Banks, John E Morley, Susan A Farr, et al.
Healthcare (Amsterdam, Netherlands)
|
June 20, 2020
Methods to identify dementia in the electronic health record: Comparing cognitive test scores with dementia algorithms
Barbara N Harding, James S Floyd, Jeffrey F Scherrer, et al.
Page
of 10